18
Participants
Start Date
December 5, 2017
Primary Completion Date
January 30, 2019
Study Completion Date
January 30, 2019
Hyperglycemic clamp
Subjects with T2D will receive IV Dextrose infusion to maintain plasma glucose at \~250 mg/dL during fMRI.
Hyperinsulinemic Euglycemic clamp
Subjects with T2D will receive IV Dextrose and Insulin infusion to maintain plasma glucose at approximately 90 mg/dL during fMRI.
Nemours Children's Health System, Jacksonville
Nemours Children's Clinic
OTHER